Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Portage Biotech Inc PRTG

Healthcare Biotechnology
Portage Biotech Inc. is a clinical-stage immuno-oncology company. The Company is engaged in advancing therapies to improve long-term treatment response, and quality of life in patients with cancers. The Company’s access to technologies coupled with biological mechanisms enables the identification of clinical therapies and product development strategies, which accelerate these medicines through... see more

Recent & Breaking News (NDAQ:PRTG)

Portage announces proposed Private Placement

PR Newswire May 19, 2015

Portage's Biohaven to begin Phase 1 study in 3Q2015 and readying for Phase 3 study start by 1Q2016

PR Newswire April 22, 2015

Portage to Present at Master Investor 2015 in London, UK

PR Newswire April 16, 2015

Portage's Biohaven Announces Agreement with inVentiv Health

PR Newswire April 1, 2015

Portage's Biohaven enters into exclusive formulation agreement and global license with Catalent for lead product

PR Newswire March 24, 2015

Portage's Biohaven Receives Response from FDA to its Pre-IND Meeting Request

PR Newswire December 18, 2014

Portage announces further successful validation of its new proprietory cell permeable peptide platform technology

PR Newswire December 16, 2014

Portage Completes Non-brokered Private Placement for a Total Proceeds of US$2,000,000

PR Newswire October 16, 2014

Portage announces additional consultants to expedite its PPL-003 development programs

PR Newswire October 6, 2014

Portage announces conversion of its debt into equity

PR Newswire September 29, 2014

Portage Announces New Consultants for its PPL-003 Development Programs

PR Newswire September 23, 2014

Portage Announces Proposed Private Placement

PR Newswire September 11, 2014

Portage's Biohaven granted United States patent for glutamate agents in the treatment of mental disorders

PR Newswire August 6, 2014

Portage announces successful validation of its new proprietory cell permeable peptide platform technology

PR Newswire July 14, 2014

Portage signs a collaborative research and development agreement with US National Institute of Health

PR Newswire May 15, 2014

Portage Signs a Collaborative Research and Development Agreement with Yale University

PR Newswire May 8, 2014

Portage's Biohaven Issued Notice of Allowance: Glutamate Agents in the Treatment of Mental Disorders

PR Newswire May 5, 2014

Portage provides updates

PR Newswire April 10, 2014

Portage reports third quarter financial results and provides updates

PR Newswire February 25, 2014

Portage acquires majority interest in Biohaven Pharmaceutical Holding Company Limited

PR Newswire January 6, 2014